Search results for "Genetically engineered"

showing 10 items of 14 documents

The hallmarks of ovarian cancer: proliferation and cell growth

2020

Epithelial ovarian cancer (EOC) is a heterogeneous group of diseases with distinct biological and clinical behaviour. Despite the differences between them, the capability of tumour cells to continuously proliferate and avoid death is maintained among histotypes. This ability is the result of alterations at different levels, causing the deregulation of cell cycle and proliferative-related pathways. Even if the leading role is played by RB and TP53, changes in other molecular pathways are involved in the development of EOC. This ability can be exploited to generate in vitro and in vivo models resembling the conditions of tumour development in a patient. In vivo models, such as patient-derived…

0301 basic medicineCancer Researchendocrine system diseaseslcsh:MedicineBiologylcsh:RC254-282Article03 medical and health sciencesCell growth0302 clinical medicinemedicineEpithelial ovarian cancerCell proliferationHeterogeneous groupCell growthlcsh:RCell cycleEpithelial ovarian cancerlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseAnimal models030104 developmental biologyOncologyTumour development030220 oncology & carcinogenesisGenetically Engineered MouseCancer researchOvarian cancerEJC Supplements
researchProduct

Paving the way for synthetic biology-based bioremediation in Europe

2009

Synthetic biology (SB) has a dual definition. It is both the design and construction of new biological parts, devices and systems, and also the re‐design of existing, natural systems for useful purposes. The latter field is maybe one of the major challenges within this discipline, since the promising prospect that biological systems may be used as biomachines will certainly be exploited in the near future. Synthetic biology has challenging conceptual possibilities (Moya et al., 2009a) and impressive progress has already been made in biotechnology following SB approaches (de Lorenzo and Danchin, 2008). Much more is expected in the near future from current efforts aiming to make synthetic gen…

0303 health sciencesInternational Genetically Engineered Machinebusiness.industryComputer science0206 medical engineeringBioengineeringEnvironmental pollutionContext (language use)02 engineering and technologyPublic opinionApplied Microbiology and BiotechnologyBiochemistryBiotechnologyLiving systemsCritical mass (sociodynamics)03 medical and health sciencesSynthetic biologyConceptual frameworkEngineering ethicsbusiness020602 bioinformatics030304 developmental biologyBiotechnologyMicrobial Biotechnology
researchProduct

A Hybrid Expressing Genetically Engineered Major Allergens of the <i>Parietaria</i> Pollen as a Tool for Specific Allergy Vaccination

2006

<i>Background:</i> Allergy is an immunological disorder affecting about 25% of the population living in the industrialized countries. Specific immunotherapy is the only treatment with a long-lasting relief of allergic symptoms and able to reduce the risk of developing new allergic sensitizations and inhibiting the development of clinical asthma in children treated for allergic rhinitis. <i>Methods:</i> By means of DNA recombinant technology, we were able to design a head to tail dimer expressing disulphide bond variants of the major allergen of the <i>Parietaria </i>pollen. IgE binding activity was studied by Western blot, ELISA inhibition assays and the …

Allergyeducation.field_of_studyParietariabiologyGenetically engineeredImmunologyPopulationSpecific immunotherapyGeneral Medicinebiology.organism_classificationmedicine.disease_causemedicine.diseaseVaccinationAllergenPollenImmunologymedicineImmunology and AllergyeducationInternational Archives of Allergy and Immunology
researchProduct

The iGEM Competition

2014

The international Genetically Engineered Machine (iGEM) competition is a well-known example of synthetic biology and a workbench for the development of heterodox, multidisciplinary and frontier work made by undergraduate students. We review the origin, organization and structure of the competition; we describe how an iGEM team can be set in place, and briefly summarize some of the main milestones and challenges of a competition that is only one decade old. We discuss the links of the competition with the Registry of Standard Biological Parts and the flagship role of iGEM as a very trench of the synthetic biology revolution.

Competition (economics)EngineeringSynthetic biologybusiness.industryInternational Genetically Engineered MachineWorld championshipRegistry of Standard Biological PartsEngineering ethicsbusinessSynthetic construct
researchProduct

Molecular studies on the toxifying effects by genetically engineered cytochromes P450.

1999

After almost two decades, it is now evident that methodology based on molecular biology and gene technology has dramatically changed the way basic and applied toxicology is being performed. It star...

Genetically engineeredComputational biologyV79 cellsBiologyCytochrome P-450 Enzyme SystemCricetinaeEnzyme InductionGene technologyAnimalsPharmacology (medical)sense organsGeneral Pharmacology Toxicology and PharmaceuticsPolycyclic Aromatic HydrocarbonsGenetic EngineeringDrug metabolism reviews
researchProduct

Experimental Hyperthermia during Cardiac Arrest and CPR Is Associated with Severe Spontaneous Hypothermia in Mice

2012

Background: Since genetically engineered mice are becoming more and more available, these animals become of high interest to study physiologic and pathophysiologic pathways of brain ischemia. The aim of this study was to examine body temperature (Tb), physical activity variation and neurohistopathology in mice exposed to normothermic and hyperthermic cardiac arrest and cardiopulmonary resuscitation (CA/CPR). Methods: Male C57Bl/6 mice weighing 22 - 27 g were implanted intraperitoneally with a radio telemeter and subjected to 10 min cardiac arrest followed by cardiopulmonary resuscitation. Normothermia (37.5°C) or hyperthermia (39.0°C) was induced by controlling pericranial temperature durin…

HyperthermiaTemperature monitoringbusiness.industryGenetically engineeredmedicine.medical_treatmentHypothermiamedicine.diseaseNeuroprotectionPathophysiologyBrain ischemiaAnesthesiamedicineCardiopulmonary resuscitationmedicine.symptombusinessNeuroscience and Medicine
researchProduct

Revised annual post-market environmental monitoring (PMEM) report on the cultivation of genetically modified maize MON 810 in 2013 from Monsanto Euro…

2015

Question number: EFSA-Q-2015-00432On request from: European Commission; Following a request from the European Commission, the Panel on Genetically Modified Organisms of the European Food Safety Authority (EFSA GMO Panel) assessed the results of the general surveillance activities contained in the revised annual post-market environmental monitoring (PMEM) report for the 2013 growing season of maize MON 810 provided by Monsanto Europe S.A. The supplied data do not indicate any unanticipated adverse effects on human and animal health or the environment arising from the cultivation of maize MON 810 cultivation in 2013. Similar methodological shortcomings to those observed in previous annual PME…

MON 810literature review[SDV]Life Sciences [q-bio]Veterinary (miscellaneous)reviewTP1-1185Plant Sciencegenetically engineered organismmaizeenvironmental impactZea maysMicrobiologyAgricultural scienceadverse effectEnvironmental monitoringTX341-641Cry1Abliterature searchestransgenic plant2. Zero hungergenetic engineeringGenetically modified maizeanimal healthNutrition. Foods and food supplyeffectChemical technologyquestionnairescreeningtransgenicsliteraturegeneral surveillancerisk assessmenthealthmethodology10079 Institute of Veterinary Pharmacology and Toxicologyfarmer questionnairestechniqueadverse effects; animal health; cultivation; effects; environmental impact; food safety; genetic engineering; genetically engineered organisms; guidelines; health; impact; literature; literature reviews; maize; methodology; monitoring; questionnaires; reviews; risk assessment; screening; techniques; transgenic plants; transgenicsfood safetymonitoringSettore AGR/11 - Entomologia Generale E ApplicataGeographycultivationimpact570 Life sciences; biologyAnimal Science and ZoologyParasitologyguidelineFood Science
researchProduct

Eugenesia y autoría moral. Lectura de una tesis habermasiana

2017

El objetivo de esta comunicación es ahondar en la visión que ha mantenido Jürgen Habermas a propósito de la manipulación genética; en concreto, se pretende abordar críticamente su hipótesis de una pérdida de autoría del sujeto manipulado. A juicio del autor, la intervención genética positiva —aquélla que tiene por objeto la introducción de virtuales mejoras en el sujeto— alcanzaría a violar la conciencia de autoría de dicho sujeto, así como su autocomprensión en tanto agente moral. En este sentido, se pretende investigar críticamente dos aspectos diferentes de la cuestión: en primer lugar, la corrección o no de la tesis habermasiana; en segundo lugar, la pertinencia o no de dicha tesis a la…

PhilosophyIntervention (law)Conceptual frameworkGenetically engineeredSubject (philosophy)Relevance (law)SociologyPositive EugenicsEpistemologyPensamiento. Revista de Investigación e Información Filosófica
researchProduct

Proteomics highlights metabolic changes associated with n-hexadecane utilization in a Streptomyces coelicolor engineered strain.

2011

Proteomics n-hexadecane utilization Streptomyces coelicolor genetically engineered strain.
researchProduct

Inducible and reversible inhibition of miRNA-mediated gene repression in vivo

2021

Although virtually all gene networks are predicted to be controlled by miRNAs, the contribution of this important layer of gene regulation to tissue homeostasis in adult animals remains unclear. Gain and loss of function experiments have provided key insights into the specific function of individual miRNAs, but effective genetic tools to study the functional consequences of global inhibition of miRNA activity in vivo are lacking. Here we report the generation and characterization of a genetically engineered mouse strain in which miRNA-mediated gene repression can be reversibly inhibited without affecting miRNA biogenesis or abundance. We demonstrate the usefulness of this strategy by invest…

Regulation of gene expressionGenetically Engineered MouseRegeneration (biology)microRNAGene regulatory networkBiologyLoss functionFunction (biology)Tissue homeostasisCell biology
researchProduct